Oxygerolan (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxygerolan, is an opioid analgesic presented as a strength/form for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxygerolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxygerolan is an opioid analgesic that acts on the central nervous system to manage pain across several clinical contexts. - Acute postoperative pain: Provides effective relief when non‑opioid analgesics are inadequate. - Cancer‑related pain: Helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: Used in selected cases where long‑term opioid therapy is justified. - Severe traumatic injury pain: Alleviates intense pain following major trauma.

Oxygerolan may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Nausea and vomiting: Mild to moderate gastrointestinal upset. - Constipation: Reduced bowel motility leading to hard stools. - Drowsiness: Sedation that may affect alertness. - Dizziness: Light‑headed sensation, especially on standing. - Dry mouth: Reduced salivary flow causing oral discomfort. - Pruritus: Itching without rash.

Serious or Rare Side Effects: - Respiratory depression: Reduced breathing rate, potentially life‑threatening. - Severe hypotension: Marked drop in blood pressure. - Opioid use disorder: Risk of dependence with prolonged use. - Adrenal insufficiency: Rare endocrine dysfunction. - Allergic reactions: Anaphylaxis or severe skin rash. - QT prolongation: Cardiac rhythm disturbance in susceptible individuals.

When prescribing Oxygerolan, clinicians should consider several safety measures to minimize risk. - Assess pain severity: Confirm that opioid therapy is appropriate for the patient’s level of pain. - Evaluate history: Screen for prior opioid use, substance abuse, or respiratory disorders. - Monitor for sedation: Observe patients for excessive drowsiness or impaired cognition. - Adjust for renal/hepatic impairment: Dose may need modification in organ dysfunction. - Educate on constipation: Recommend laxatives or stool softeners as needed. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Oxygerolan can interact with several medication classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - CNS depressants: Concurrent use with benzodiazepines or barbiturates can cause profound respiratory depression. - MAO inhibitors: May precipitate severe hypertension or serotonin syndrome. - CYP3A4 inhibitors: Strong inhibitors (e.g., ketoconazole) can increase oxycodone plasma levels.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors: Medications like fluoxetine may modestly raise oxycodone concentrations. - Anticholinergics: May exacerbate constipation. - Diuretics: Can enhance orthostatic hypotension risk.